| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―Jun―05 |
The In Silico Study of Bioactive Compounds from Some Tropical Trees as Inhibitors of Papain-Like Protease SARS-COV-2 |
Syamsul Falah, Shobiroh Nuur’Alimah, Laksmi Ambarsari |
| 2 |
[GO] |
2024―Dec―16 |
Exploring The Inhibition of SARS-COV-2 PLpro: Docking and Molecular Dynamics Simulation of Flavonoid in Red Fruit Papua and Its Derivatives |
Agus Dwi Ananto, Harno Dwi Pranowo, Winarto Haryadi, Niko Prasetyo |
| 3 |
[GO] |
2024―Dec―16 |
The comparison of the Sensitivity Value of Gold Nanoparticles (AuNPs) between ANTAM and Commercial Gold Sources in the Detection of SARS-CoV-2: A Preliminary Study |
Istianah Istianah, Agustina Vidiawati, Akhmad Irfan Alfiyan, Agustina Sus Andreani |
| 4 |
[GO] |
2023―Dec―02 |
The Exploration of Bioactive Peptides that Docked to SARS-CoV-2 Spike Protein from Goats’ Milk Beta-Casein by In Silico |
Hermawan Setyo Widodo, Tridjoko Wisnu Murti, Ali Agus, Ambar Pertiwiningrum |
| 5 |
[GO] |
2023―Mar―27 |
Virtual Screening of Natural Compounds Against Six Protein Receptors Coded by The SARS-CoV-2 Genome |
Fikry Awaluddin, Irmanida Batubara, Setyanto Tri Wahyudi |
| 6 |
[GO] |
2022―Dec―02 |
Potential Indonesian Natural Compound as antiviral for COVID-19 targeting the RdRp: In silico Study |
Zahra Silmi Muscifa, Tony Sumaryada, Laksmi Ambarsari, Setyanto Tri Wahyudi |
| 7 |
[GO] |
2022―Apr―01 |
Molecular Docking of Xanthone Derivatives as Therapeutic Agent for Covid-19 |
Emmy Yuanita, Sudirman Sudirman, Ni Komang Tri Dharmayani, Maria Ulfa, Saprizal Hadisaputra, Jufrizal Syahri |
| 8 |
[GO] |
2021―Aug―02 |
Computational Study of Scorpion Venom (Lychas Mucronatus) Activity as Antimicrobial Peptides (AMPs) to the SARS-CoV-2 Main Protease for the Future Coronavirus Disease (COVID-19) Inhibitors |
Taufik Muhammad Fakih |
